Islet amyloid polypeptide decreases the effects of insulin-like growth factor-I on glucose transport and glycogen synthesis in skeletal muscle

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 9, 1998, Pages 1039-1046

  Dimitriadis, George ^a,c   Crowne, Elizabeth ^a   Clark, Anne ^b   Dunger, David B ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c NONE   (Greece)

Author keywords

Glycogen synthesis; Insulin, glucose transport; Insulin like growth factor I; Islet amyloid polypeptide; Skeletal muscle

Indexed keywords

AMYLIN; GLUCOSE; LACTIC ACID; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; ISOTOPE LABELING; MALE; NONHUMAN; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

AMYLOID; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; GLUCOSE; GLYCOGEN; GLYCOLYSIS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; KINETICS; LACTIC ACID; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR;

EID: 0031730083     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00063-6     Document Type: Article

References (35)

1. A. Clark, G. Cooper, C. Lewis, J. Morris, A. Willis, K. Reid, R. Turner, Islet amyloid formed from diabetes-associated peptide may be pathogenic in Type II diabetes, Lancet 2 (1987) 232-234.
2. P. Westermark, C. Wernstedt, E. Wilander, D. Hayden, T. O'Brien, K. Johnson, Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells, Proc. Natl. Acad. Sci. (USA) 84 (1987) 3881-3885.
3. G. Copper, A. Willis, A. Clark, R. Turner, R. Sim, K. Reid, Purification and characterization of a peptide from amyloid-rich pancreases of Type II diabetes, Proc. Natl. Acad. Sci. (USA) 84 (1987) 8628-8632.
4. A. Clark, Islet amyloid: an enigma of Type II diabetes, Diabetes/Metabolism Rev. 8 (2) (1992) 117-132.
5. G. Cooper, B. Leighton, G. Dimitriadis, M. Parry-Billings, J. Kowalchuk, K. Howland, J. Rothbard, A. Willis, K. Reid, Amylin found in amyloid deposits in human Type II diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle, Proc. Natl. Acad. Sci. (USA) 85 (1988) 7763-7766.
6. A. Young, R. Pittner, B. Gedulin, W. Vine, T. Rink, Amylin regulation of carbohydrate metabolism, Biochem. Soc. Trans. 23 (1995) 325-331.
7. E. Newsholme, G. Dimitriadis, Interaction of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentrations, in: D. LeRoith, J. Olefsky, S. Taylor (Eds.), Diabetes Mellitus: a Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, 1996, pp. 263-275.
8. B. Leighton, G. Cooper, Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in-vitro, Nature 335 (1988) 632-635.
9. A. Young, B. Gedulin, D. Wolfe-Lopez, H. Greene, T. Rink, G. Cooper, Amylin and insulin in rat soleus muscle: dose-response for co-secreted non-competitive antagonists, Am. J. Physiol. 263 (1992) E274-E281.
10. J. Zierath, D. Galuska, A. Engstrom, K. Jonnson, C. Betsholtz, P. Westermark, H. Wallberg-Henriksson, Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in-vitro incubated human muscle strips, Diabetologia 35 (1992) 26-31.
11. A. Young, R. Deems, R. Deacon, R. McIntosh, J. Foley, Effects of amylin on glucose metabolism and glycogen-olysis in-vivo and in-vitro, Am. J. Physiol. 259 (1990) E457-E461.
12. B. Leighton, E. Foot, The effects of amylin on carbohydrate metabolism in skeletal muscle in-vitro and invivo, Biochem. J. 269 (1990) 19-23.
13. D. Kreutter, S. Orena, A. Torchia, L. Contillo, G. Andrews, R. Stevenson, Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor, Am. J. Physiol. 264 (1993) E606-613.
14. M. Adamo, Regulation of insulin-like growth factor I gene-expression, Diabetes Rev. 3 (1) (1995) 2-27.
15. R. Bhogal, D. Smith, P. Purkiss, S. Bloom, Molecular identification of binding sites for calcitonin-gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP, Endocrinology 133 (1993) 2351-2361.
16. E. Rinderknecht, R. Humbel, The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin, J. Biol. Chem. 253 (1978) 2769-2776.
17. J. Massague, M. Czech, The subunit structure of two distinct receptors for IGFs I and II and their relationship to the insulin receptor, J. Biol. Chem. 257 (1982) 5038-5045.
18. C. Poggi, Y. LeMarchand-Brustel, J. Zapf, R. Froesch, P. Freychet, Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice, Endocrinology 105 (1979) 723-730.
19. G. Dimitriadis, M. Parry-Billings, S. Bevan, D. Dunger, T. Piva, U. Krause, G. Wegener, E. Newsholme, Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in-vitro, Biochem. J. 285 (1992) 269-274.
20. G. Dimitriadis, M. Parry-Billings, D. Dunger, S. Bevan, A. Colqhoun, A. Taylor, P. Calder, U. Krause, G. Wegener, E. Newsholme, Effects of in-vivo administration of insulin-like growth factor I on the rate of glucose utilization in the soleus muscle of the rat, J. Endocrinol. 133 (1992) 37-43.
21. L. Rossetti, S. Frontoni, R. Dimarchi, R. DeFronzo, A. Giaccari, Metabolic effects of IGF-I in diabetic rats, Diabetes 40 (1991) 444-448.
22. N. Dozio, M. Scavini, A. Beretta, S. Sartori, F. Meschi, E. Sarugeri, G. Pozza, In-vivo metabolic effects of insulin-like growth factor I are not mediated through the insulin receptor, J. Clin. Endocrinol. Metab. 80 (1995) 1325-1328.
23. M. Savage, D.B. Dunger, Recombinant IGF-I therapy in insulin-dependent diabetes mellitus, Diabetes Metabolism (Paris) 22 (1996) 257-260.
24. K. Cusi, R. DeFronzo, Treatment of NIDDM, IDDM and other insulin resistant states with IGF-I, Diabetes Rev. 3 (2) (1995) 206-236.
25. J. Espinal, L. Dohm, E. Newsholme, Sensitivity to insulin of glycolysis and glycogen synthesis of isolated soleus muscle strips from sedentary, exercised and exercise-trained rats, Biochem. J. 212 (1983) 453-458.
26. J. Challiss, J. Arch, E. Newsholme, The rate of substrate cycling between fructose 6-phosphate and fructose 1,6-bisphosphate, Biochem. J. 221 (1984) 153-161.
27. G. Dimitriadis, M. Parry-Billings, B. Leighton, T. Piva, D. Dunger, P. Calder, J. Bond, E. Newsholme, Studies on the effects of growth hormone administration in-vivo on the rates of glucose transport and utilization in rat skeletal muscle, Eur. J. Clin. Invest. 24 (1994) 161-165.
28. H. Guler, J. Zapf, R. Froesch, Short-term metabolic effects of recombinant insulin-like growth factor I in healthy adults, N. Engl. J. Med. 317 (1987) 137-140.
29. J. Zapf, C. Hauri, M. Waldvogel, R. Froesch, Acute metabolic effects and half-lives of intravenously administered insulin-like growth factor I in normal and hypophysectomized rats, J. Clin. Invest. 77 (1986) 1768-1775.
30. S. Sheriff, J. Fisher, A. Balasubramaniam, Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin sensitive mechanism, Biochim. Biophys. Acta 1136 (1992) 219-222.
31. F. Dimitriadis, B. Leighton, M. Parry-Billings, S. Sasson, M. Young, U. Krause, S. Bevan, T. Piva, G. Wegener, E. Newsholme, Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle, Biochem. J. 321 (1997) 707-712.
32. M. Myers, X. Sun, B. Cheetham, Differential signalling potential of insulin and IGF-I receptor cytoplasmic domains, EMBO J. 8 (1989) 1369-1375.
33. M. Soos, J. Whittaker, R. Lammers, A. Ullrich, K. Siddle, receptors for insulin and insulin-like growth factor I can form hybrid dimers: characterization of hybrid receptors in transfected cells, Biochem. J. 270 (1990) 383-390.
34. M. Soos, C. Field, K. Siddle, Purified hybrid insulin/ insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290, (1993) 419-425.
35. A. Chanty, B. Leighton, A. Day, Cross-reactivity of amylin with calcitonin-gene related peptide binding sites in rat liver and skeletal muscle membranes, Biochem. J. 277 (1991) 139-143.